证券记录 · 已归档季度
ENTA
Enanta Pharmaceuticals, Inc. · Healthcare · Biotechnology
12被追踪持有人
0Δ持有人
8.38M持有股份
$63.38M报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +0.8% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | -3 | 10.74M | $156.55M | +2 | −5 |
| Q1 2026 | 62 | -2 | 14.86M | $187.69M | +5 | −7 |
| Q4 2025 | 64 | +3 | 16.10M | $253.79M | +3 | — |
| Q3 2025 | 16 | +1 | 7.96M | $95.31M | +2 | −1 |
| Q2 2025 | 12 | 0 | 8.38M | $63.38M | — | — |
| Q1 2025 | 9 | -2 | 4.49M | $24.81M | — | −2 |
| Q4 2024 | 11 | -1 | 4.05M | $23.26M | — | −1 |
| Q3 2024 | 11 | +2 | 4.15M | $43.00M | +2 | — |
| Q2 2024 | 9 | — | 3.87M | $50.19M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 1.98M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 1.98M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 1.98M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.46M | +8.3% | $11.03M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Marshall Wace ✦ | 857.41K | +0.8% | $6.48M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 857.41K | +0.8% | $6.48M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Geode Capital Management ✦ (被动) | 485.80K | -1.7% | $3.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Geode Capital Management ✦ (被动) | 485.80K | -1.7% | $3.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (被动) | 470.27K | +3.3% | $3.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 469.50K | +1.3% | $3.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 282.28K | -26.4% | $2.13M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 282.28K | -26.4% | $2.13M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 78.45K | +0.7% | $593,120 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 59.14K | -8.9% | $447,129 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 1.79K | — | $13,540 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 1.79K | — | $13,540 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 131 持有人, 26.72M 股份, $290.62M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 14
SC 13G/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
Aug 14
SC 13G/A — Deep Track Capital, LP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据